売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2024/6 |
23,976 |
2.0% |
| 2023/6 |
7,045 |
4.8% |
| 2022/6 |
17,081 |
5.6% |
| 2021/6 |
175 |
53.7% |
| 2020/6 |
1,415 |
89.7% |
| 2019/6 |
76 |
|
| 2018/6 |
11 |
|
| 2017/6 |
141 |
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2024/6 |
-12,125 |
-50.6% |
| 2023/6 |
-9,685 |
-137.5% |
| 2022/6 |
-7,237 |
-42.4% |
| 2021/6 |
-4,861 |
-2775.7% |
| 2020/6 |
-1,905 |
-134.7% |
|
(単位:千ドル)
|
2016/6
|
2017/6
|
2018/6
|
2019/6
|
2020/6
|
2021/6
|
2022/6
|
2023/6
|
2024/6
|
|
売上高
|
-
|
140
|
10
|
75
|
1,414
|
175
|
17,080
|
7,045
|
23,975
|
|
売上成長率(%)
|
-
|
-
|
|
|
1765.0
|
-87.6
|
9652.8
|
-58.8
|
240.3
|
|
売上原価
|
-
|
85
|
4
|
-
|
146
|
81
|
16,125
|
6,704
|
23,501
|
|
売上総利益
|
-
|
55
|
5
|
-
|
1,268
|
94
|
955
|
340
|
474
|
|
売上総利益率(%)
|
-
|
|
|
-
|
89.7
|
53.7
|
5.6
|
4.8
|
2.0
|
|
研究開発費
|
-
|
-
|
361
|
168
|
1,114
|
851
|
1,259
|
921
|
359
|
|
営業費用
|
1,122
|
1,308
|
1,667
|
1,499
|
3,173
|
4,955
|
8,192
|
10,026
|
12,599
|
|
営業利益
|
-
|
-
|
-
|
-
|
-1,906
|
-4,862
|
-7,238
|
-9,686
|
-12,126
|
|
営業利益率 (%)
|
-
|
-
|
-
|
-
|
-134.7
|
-2775.7
|
-42.4
|
-137.5
|
-50.6
|
|
経常(税引前)利益
|
-1,123
|
-1,254
|
-1,662
|
-1,500
|
-1,859
|
-4,885
|
-7,112
|
-9,699
|
-11,388
|
|
経常(税引前)利益率(%)
|
-
|
-890.5
|
-15716.8
|
-1976.4
|
-131.3
|
-2788.8
|
-41.6
|
-137.7
|
-47.5
|
|
法人税等合計
|
-
|
-
|
-
|
-
|
5
|
-
|
-
|
-
|
-
|
|
実効税率(%)
|
-
|
-
|
-
|
-
|
-0.3
|
-
|
-
|
-
|
-
|
|
純利益
|
-1,125
|
-1,194
|
-1,605
|
-1,426
|
-1,864
|
-4,649
|
-6,522
|
-9,480
|
-11
|
|
純利益率(%)
|
-
|
|
|
|
-131.7
|
-2654.2
|
-38.2
|
-134.6
|
0.0
|
|
一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.27
|
-0.38
|
-4.38
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.27
|
-0.38
|
-4.38
|
|
EBITDA
|
-
|
-
|
-
|
-
|
-1,795
|
-4,663
|
-6,660
|
-8,984
|
-
|
|
EBITDAマージン(%)
|
-
|
-
|
-
|
-
|
-126.9
|
-2661.9
|
-39.0
|
-127.5
|
-
|